Latest News & Features
Big Pharma
Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over. 12 October 2020
Genetics
The Federal Court of Australia has refused to block a cattle genome patent from the US, dismissing an appeal from Meat and Livestock Australia. 12 October 2020
Americas
US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1. 8 October 2020
Big Pharma
South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries. 8 October 2020
article
As businesses around the world evaluate their options for protecting new technologies, trade secret protection can be an essential complement to patents. In this session, we will evaluate the use of trade secrets protection as an alternative to patenting. 8 October 2020
Americas
French microbiologist Emmanuelle Charpentier and US biochemist Jennifer Doudna have achieved scientific history by jointly winning the Nobel Prize in chemistry for their seminal work on gene-editing technology, CRISPR. 8 October 2020
Biotechnology
Regeneron Pharmaceuticals is facing claims that its “antibody cocktail”, which was administered to President Donald Trump to treat his COVID-19 symptoms, was developed with the unauthorised use of a fluorescent protein. 6 October 2020
Americas
Bristol Myers Squibb has announced it will acquire biotech firm MyoKardia for $13.1 billion, strengthening its portfolio of heart disease treatments. 6 October 2020
Big Pharma
In a victory for GlaxoSmithKline, the US Court of Appeals for the Federal Circuit has revived a 2017 jury verdict ordering Teva to pay $235 million over the drug Coreg. 6 October 2020
Americas
A US appeals court has cancelled a $448 million antitrust bill for AbbVie, in a blow for the US Federal Trade Commission. 2 October 2020